These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
880 related articles for article (PubMed ID: 21728338)
1. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells. Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338 [TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. Song NY; Kim DH; Kim EH; Na HK; Surh YJ Ann N Y Acad Sci; 2009 Aug; 1171():210-6. PubMed ID: 19723058 [TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. Kim JW; Li MH; Jang JH; Na HK; Song NY; Lee C; Johnson JA; Surh YJ Biochem Pharmacol; 2008 Dec; 76(11):1577-89. PubMed ID: 18775681 [TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. Kim EH; Na HK; Kim DH; Park SA; Kim HN; Song NY; Surh YJ Carcinogenesis; 2008 Apr; 29(4):688-95. PubMed ID: 18192694 [TBL] [Abstract][Full Text] [Related]
6. 15-deoxy-Δ12,14-prostaglandin J₂ induces p53 expression through Nrf2-mediated upregulation of heme oxygenase-1 in human breast cancer cells. Kim DH; Song NY; Kim EH; Na HK; Joe Y; Chung HT; Surh YJ Free Radic Res; 2014 Sep; 48(9):1018-27. PubMed ID: 24568186 [TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-Δ Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515 [TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. Kim DH; Kim JH; Kim EH; Na HK; Cha YN; Chung JH; Surh YJ Carcinogenesis; 2009 Apr; 30(4):645-54. PubMed ID: 19136476 [TBL] [Abstract][Full Text] [Related]
9. 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species. Kitz K; Windischhofer W; Leis HJ; Huber E; Kollroser M; Malle E Free Radic Biol Med; 2011 Apr; 50(7):854-65. PubMed ID: 21236332 [TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. Paumi CM; Wright M; Townsend AJ; Morrow CS Biochemistry; 2003 May; 42(18):5429-37. PubMed ID: 12731885 [TBL] [Abstract][Full Text] [Related]
11. The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂-treated endothelial cells. Lin YC; Huang GD; Hsieh CW; Wung BS Free Radic Biol Med; 2012 May; 52(9):1844-53. PubMed ID: 22387200 [TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism. Reyes-Martin P; Ramirez-Rubio S; Parra-Cid T; Bienes-Martínez R; Lucio-Cazana J Pharmacol Res; 2008 May; 57(5):344-50. PubMed ID: 18456507 [TBL] [Abstract][Full Text] [Related]
13. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells. Deng X; Rui W; Zhang F; Ding W Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690 [TBL] [Abstract][Full Text] [Related]
14. 15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells. Kang ES; Hwang JS; Ham SA; Park MH; Kim GH; Paek KS; Yoo T; Lee WJ; Kang KR; Lee JH; Choi YJ; Seo HG Free Radic Res; 2014 Feb; 48(2):218-29. PubMed ID: 24180671 [TBL] [Abstract][Full Text] [Related]
15. Lico A Enhances Nrf2-Mediated Defense Mechanisms against t-BHP-Induced Oxidative Stress and Cell Death via Akt and ERK Activation in RAW 264.7 Cells. Lv H; Ren H; Wang L; Chen W; Ci X Oxid Med Cell Longev; 2015; 2015():709845. PubMed ID: 26576227 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Grau R; Iñiguez MA; Fresno M Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320 [TBL] [Abstract][Full Text] [Related]
17. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells. Kim DH; Kim EH; Na HK; Surh YJ Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. Saito Y; Nishio K; Numakawa Y; Ogawa Y; Yoshida Y; Noguchi N; Niki E J Neurochem; 2007 Sep; 102(5):1625-1634. PubMed ID: 17697048 [TBL] [Abstract][Full Text] [Related]
19. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. Winnett G; van Hagen D; Schrey M Int J Cancer; 2003 Feb; 103(5):600-5. PubMed ID: 12494466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]